| Bioactivity | Pioglitazone-d4 is a deuterium labeled Pioglitazone. Pioglitazone (U 72107) is a potent and selective PPARγ agonist with high affinity binding to the PPARγ ligand-binding domain with EC50 of 0.93 and 0.99 μM for human and mouse PPARγ, respectively[1]. | |||||||||
| Name | Pioglitazone-d4 | |||||||||
| CAS | 1134163-29-3 | |||||||||
| Formula | C19H16D4N2O3S | |||||||||
| Molar Mass | 360.46 | |||||||||
| Appearance | Solid | |||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | |||||||||
| Storage |
|
|||||||||
| Reference | [1]. Kuwabara K, et al. A novel selective peroxisome proliferator-activated receptor alpha agonist, 2-methyl-c-5-[4-[5-methyl-2-(4-methylphenyl)-4-oxazolyl]butyl]-1,3-dioxane-r-2-carboxylic acid (NS-220), potently decreases plasma triglyceride and glucose leve |
Pioglitazone-d4
CAS: 1134163-29-3 F: C19H16D4N2O3S W: 360.46
Pioglitazone-d4 is a deuterium labeled Pioglitazone. Pioglitazone (U 72107) is a potent and selective PPARγ agonist wit
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.